Cafepharma Today

June 3 2025 - Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Merck made $3B-plus offer for MoonLake—and could revive interest in late-phase biotech
Arrowhead commences dosing in Phase I/IIa obesity treatment trial
ASCO: Bristol Myers CMO brushes off LAG-3 concern in lung cancer after Opdualag's adjuvant melanoma flop
Amid staff cuts, FDA looks to AI to 'optimize' reviews
*please scroll down for all the latest news *

Make it like cafepharma, but for different industries. Learn more about CompanyUnderground

Check open job listings in your area
Click here to stay updated on CP happenings

learn about pharmaceutical fraud
learn about the False Claims Act
learn about clinical lab fraud

Current News

submit a press release

Billionaire Bill Ackman, Valeant Want To Takeover Botox-Maker Allergan
Forbes
Monday, April 21, 2014 - 5:03pm
tags:
Valeant Pharmaceuticals, M&A, Allergan
Pfizer agrees to $190 mln settlement over generic Neurontin
Yahoo/Reuters
Monday, April 21, 2014 - 4:59pm
tags:
Pfizer, generics, Neurontin, epilepsy
Lilly’s Gastric Cancer Drug Wins Approval From U.S. FDA
Bloomberg
Monday, April 21, 2014 - 4:58pm
tags:
Eli Lilly, gastric cancer, FDA, ramucirumab
New GlaxoSmithKline Diabetes Drug Needs Innovative Marketing Strategy
Seeking Alpha
Monday, April 21, 2014 - 4:51pm
tags:
GSK, diabetes, Tanzeum
What a Combined Pfizer and AstraZeneca Would Look Like, and Face
24/7WallStreet
Monday, April 21, 2014 - 4:48pm
tags:
Pfizer, M&A, AstraZeneca
Success Of Rexahn's Nano-Sized Taxotere Can Help Big Pharma Ease Patent Cliff
Seeking Alpha
Monday, April 21, 2014 - 4:46pm
tags:
Taxotere, Rexahn, RX-21101, patents, patent cliff, Bristol-Myers Squibb, Roche, Sanofi
Nothing Generic About Mylan
Forbes
Monday, April 21, 2014 - 4:44pm
tags:
generics, Mylan
Warfarin's Loss is Johnson & Johnson's Gain
Motley Fool
Monday, April 21, 2014 - 4:20pm
tags:
JNJ, bloodthinners, Warfarin, Pradaxa, Xarelto, Boehringer Ingelheim
Gilead Results Can Affect The Entire Market
Seeking Alpha
Monday, April 21, 2014 - 11:45am
tags:
Gilead Sciences, Sovaldi, earnings
Should Pfizer Attempt To Acquire AstraZeneca?
Seeking Alpha
Monday, April 21, 2014 - 11:43am
tags:
Pfizer, M&A, AstraZeneca
No Legwork Mondays – Takeda, Eli Lilly, And Actos
Yahoo/Benzinga
Monday, April 21, 2014 - 11:39am
tags:
Takeda, Eli Lilly, Actos, diabetes
Docs that just say no to drug samples slash brand prescribing big-time, study finds
Fierce Pharma
Monday, April 21, 2014 - 11:38am
tags:
samples, physicians
Today's Market: Other Potential Buyout Targets For Pfizer
Seeking Alpha
Monday, April 21, 2014 - 11:25am
tags:
M&A, Pfizer, AstraZeneca, Celgene, Biogen Idec, Amgen
Arena Pharmaceuticals' Belviq Sales Dip - Why?
Seeking Alpha
Monday, April 21, 2014 - 11:21am
tags:
Arena Pharmaceuticals, Belviq
Sarepta Surges on Optimism Over Muscular Dystrophy Drug
Bloomberg
Monday, April 21, 2014 - 10:32am
tags:
Sarepta Therapeutics, Duchenne Muscular Dystrophy, eteplirsen
Aastrom announces definitive agreement to acquire Sanofi's CTRM business
The Fly on the Wall
Monday, April 21, 2014 - 10:30am
tags:
Aastrom Biosciences, M&A, Sanofi, CTRM, cell therapy
Potential Impact On R&D Of A Pfizer Takeover Of AstraZeneca
Forbes
Monday, April 21, 2014 - 10:26am
tags:
R&D, Pfizer, AstraZeneca, M&A
Analysts differ on chances of Pfizer interest in AstraZeneca
The Fly on the Wall
Monday, April 21, 2014 - 10:23am
tags:
Pfizer, M&A, AstraZeneca
Will Edwards Snatch Defeat From The Jaws Of Its Victory Over Medtronic?
Forbes
Monday, April 21, 2014 - 10:21am
tags:
Medtronic, Edwards Lifesciences, devices, TAVR, patents
Johnson & Johnson's New Diabetes Drug: A Blockbuster in the Making?
Motley Fool
Monday, April 21, 2014 - 10:17am
tags:
JNJ, diabetes, Invokana

Pages

Latest CP Wire Articles

Hermes Intelligence Launches to Redefine Pharma Data Solutions [sponsored]
The Evolution of Medical Sales: What’s Changing in 2025?
FDA Scraps Key Vaccine Meetings—What It Means for Manufacturers
FDA approves Danziten, the first nilotinib treatment for Ph+ CML with no mealtime restrictions
Daily U.S. Flu Cases Expected to Nearly Double from Last Year by Late November, Predicts Novel Mathematical Forecasting Tool
PharmaBlock Receives 2024 ACS CMO Excellence in Green Chemistry Award, Marking a Second Consecutive Year of Recognition
Leading Clinical Research Network Centricity Research Acquires North Carolina-based Lucas Research
First-of-Its-Kind Alzheimer’s Disease Simulation Paves Way for Personalized Treatment: Penn State, Duke University Study
Centricity Research Appoints New CEO, CFO to Support Next Phase of Growth
Sermo Barometer Examines Influencers’ Impact on Patient Perceptions of Weight Loss Medications & Preventative Care Technologies

Latest Pharmagather Articles

Taurine Revisited
In the Pipeline
A New Route to Asthma Treatment - Through the Liver, of All Places
In the Pipeline
One Drug's Supply Chain, In Detail
In the Pipeline
A Reaction to Alzheimer's Fraud
In the Pipeline
Whoa Now: Cautionary Tales from Materials Science
In the Pipeline
Inside a Scientific Paper Mill
In the Pipeline
Autoimmune Disease, Transformed?
In the Pipeline
Lose Your Crystalline Form and Go Amorphous
In the Pipeline
Alzheimer's Update: Infectious Agents and Gamma-Secretase Too
In the Pipeline

current feelings about your job

Please rate how you feel about your job this moment. 1 = "I hate my job" and 7 = "I love my job"
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Fill in the blank.